NFE2L2 and amyotrophic lateral sclerosis: Additionally, the treatment with LPS in a Nrf2 (−/−) mice model with amyotrophic lateral sclerosis (ALS) showed elevated NF-κB activity and an increase in cytokine production that contributed to astrogliosis, neuronal death, and demyelination of neuronal axons [57].